BP
About
Biohaven is a clinical-stage biopharmaceutical company. It has a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders. The company product candidates are based on multiple mechanisms-calcitonin gene-related peptide receptor antagonists, glutamate modulators and myeloperoxidase inhibitor. Its pipeline products include BHV3000-301, BHV3000-302, BHV3000-303, and others.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 58 investors are based in New Haven, Connecticut, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- New Haven, US
Contact Information
Find more investors like Biohaven
Search Investors